BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35235554)

  • 1. Novel mutation in hexokinase 2 confers resistance to 2-deoxyglucose by altering protein dynamics.
    Hellemann E; Walker JL; Lesko MA; Chandrashekarappa DG; Schmidt MC; O'Donnell AF; Durrant JD
    PLoS Comput Biol; 2022 Mar; 18(3):e1009929. PubMed ID: 35235554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous mutations that confer resistance to 2-deoxyglucose act through Hxk2 and Snf1 pathways to regulate gene expression and HXT endocytosis.
    Soncini SR; Chandrashekarappa DG; Augustine DA; Callahan KP; O'Donnell AF; Schmidt MC
    PLoS Genet; 2020 Jul; 16(7):e1008484. PubMed ID: 32673313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of HAD-like phosphatases by multiple signaling pathways confers resistance to the metabolic inhibitor 2-deoxyglucose.
    Defenouillère Q; Verraes A; Laussel C; Friedrich A; Schacherer J; Léon S
    Sci Signal; 2019 Sep; 12(597):. PubMed ID: 31481524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of yeast hexokinase: structural requirements for triggering cAMP signalling and catabolite repression.
    Kraakman LS; Winderickx J; Thevelein JM; De Winde JH
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):159-68. PubMed ID: 10493925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-deoxyglucose transiently inhibits yeast AMPK signaling and triggers glucose transporter endocytosis, potentiating the drug toxicity.
    Laussel C; Albanèse V; García-Rodríguez FJ; Ballin A; Defenouillère Q; Léon S
    PLoS Genet; 2022 Aug; 18(8):e1010169. PubMed ID: 35951639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of 6-deoxyglucose in Saccharomyces cerevisiae.
    Bisson LF; Fraenkel DG
    J Bacteriol; 1983 Sep; 155(3):995-1000. PubMed ID: 6350275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel alleles of yeast hexokinase PII with distinct effects on catalytic activity and catabolite repression of SUC2.
    Hohmann S; Winderickx J; de Winde JH; Valckx D; Cobbaert P; Luyten K; de Meirsman C; Ramos J; Thevelein JM
    Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():703-714. PubMed ID: 10217505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of xylose uptake in 2-deoxyglucose tolerant mutant of Saccharomyces cerevisiae.
    Kahar P; Taku K; Tanaka S
    J Biosci Bioeng; 2011 May; 111(5):557-63. PubMed ID: 21257343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation Ser213/Asn in the hexokinase 1 from Schizosaccharomyces pombe increases its affinity for glucose.
    Petit T; Herrero P; Gancedo C
    Biochem Biophys Res Commun; 1998 Oct; 251(3):714-9. PubMed ID: 9790975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological properties of Saccharomyces cerevisiae from which hexokinase II has been deleted.
    Diderich JA; Raamsdonk LM; Kruckeberg AL; Berden JA; Van Dam K
    Appl Environ Microbiol; 2001 Apr; 67(4):1587-93. PubMed ID: 11282609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to 2-deoxyglucose in yeast: a direct selection of mutants lacking glucose-phosphorylating enzymes.
    Lobo Z; Maitra PK
    Mol Gen Genet; 1977 Dec; 157(3):297-300. PubMed ID: 340926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Sapir G; Harris T; Uppala S; Nardi-Schreiber A; Sosna J; Gomori JM; Katz-Brull R
    Sci Rep; 2019 Dec; 9(1):19683. PubMed ID: 31873121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic mapping in mammalian retina: a biochemical and 3H-2-deoxyglucose autoradiographic study.
    Winkler BS; Pourcho RG; Starnes C; Slocum J; Slocum N
    Exp Eye Res; 2003 Sep; 77(3):327-37. PubMed ID: 12907165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a hexokinase II deletion on the dynamics of glycolysis in continuous cultures of Saccharomyces cerevisiae.
    Diderich JA; Raamsdonk LM; Kuiper A; Kruckeberg AL; Berden JA; Teixeira de Mattos MJ; van Dam K
    FEMS Yeast Res; 2002 May; 2(2):165-72. PubMed ID: 12702304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxyglucose impairs Saccharomyces cerevisiae growth by stimulating Snf1-regulated and α-arrestin-mediated trafficking of hexose transporters 1 and 3.
    O'Donnell AF; McCartney RR; Chandrashekarappa DG; Zhang BB; Thorner J; Schmidt MC
    Mol Cell Biol; 2015 Mar; 35(6):939-55. PubMed ID: 25547292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saccharomyces cerevisiae null mutants in glucose phosphorylation: metabolism and invertase expression.
    Walsh RB; Clifton D; Horak J; Fraenkel DG
    Genetics; 1991 Jul; 128(3):521-7. PubMed ID: 1874414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of resistance and sensitivity to 2-deoxyglucose in Saccharomyces cerevisiae.
    McCartney RR; Chandrashekarappa DG; Zhang BB; Schmidt MC
    Genetics; 2014 Oct; 198(2):635-46. PubMed ID: 25116136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit.
    Gerbitz KD; Gempel K; Brdiczka D
    Diabetes; 1996 Feb; 45(2):113-26. PubMed ID: 8549853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinases.
    Blázquez MA; Lagunas R; Gancedo C; Gancedo JM
    FEBS Lett; 1993 Aug; 329(1-2):51-4. PubMed ID: 8354408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed and diverse metabolic and gene-expression regulation of the glycolytic and fermentative pathways in response to a HXK2 deletion in Saccharomyces cerevisiae.
    Rossell S; Lindenbergh A; van der Weijden CC; Kruckeberg AL; van Eunen K; Westerhoff HV; Bakker BM
    FEMS Yeast Res; 2008 Feb; 8(1):155-64. PubMed ID: 17662056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.